findmyKOL
Clinical trialNCT00470470CompletedPhase 2Interventional

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

SponsorNational Cancer Institute (NCI)Enrollment30Acral Lentiginous Malignant MelanomaRecurrent MelanomaStage IIIA MelanomaStage IIIB MelanomaStage IIIC MelanomaStage IV Melanoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California at Los Angeles (ucla )

    Los Angeles, California, United States

  • Mount Sinai Medical Center Ccop

    Miami Beach, Florida, United States

  • Good Samaritan Medical Center

    West Palm Beach, Florida, United States

  • Palm Beach Cancer Institute-Main Office

    West Palm Beach, Florida, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Mount Sinai Medical Center

    New York, New York, United States

  • New York University Langone Medical Center

    New York, New York, United States

  • Weill Medical College of Cornell University

    New York, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2007
Primary completion
31 Dec 2013
Completion
31 Oct 2014
Last update posted
23 Dec 2014
Registered enrollment
30
Registry id
NCT00470470

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.